Tokushima, Japan

Hideji Nonomura

This inventor holds 3 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignee: Otsuka Pharmaceutical Company, Limited. Active years: 2004-2009.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hideji Nonomura. Retrieved from https://idiyas.com/inventor/hideji-nonomura

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 3 


Average Co-Inventor Count = 4.7

ph-index = 2

Forward Citations = 5(Granted Patents)


Location History:

  • Tokushima, JP (2006)
  • Tokushima-ken, JP (2004 - 2009)

Company Filing History:


Years Active: 2004-2009

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Hideji Nonomura - Innovator in Diagnostic Methods for Irritable Bowel Syndrome

Introduction

Hideji Nonomura is an inventor based in Yoshinogawa-shi, Japan. He has made significant contributions to the field of medical diagnostics, particularly concerning irritable bowel syndrome (IBS). His innovative approach focuses on the detection of abnormal proliferation of enterobacteria, which is linked to the onset of IBS.

Latest Patent Applications

Nonomura's notable patent application is titled "DIAGNOSTIC AGENT AND DIAGNOSTIC METHOD FOR IRRITABLE BOWEL SYNDROME INDUCED BY ABNORMAL PROLIFERATION OF ENTEROBACTERIA." The problem he aims to solve is the need for a reliable diagnostic agent to determine the onset of IBS. The solution he proposes involves a diagnostic agent that detects abnormal proliferation of enterobacteria in patients suspected of suffering from IBS. This agent contains a compound that is decomposed by enterobacteria and is labeled with a carbon isotope.

Conclusion

Hideji Nonomura's work represents a significant advancement in the diagnostic methods for irritable bowel syndrome. His innovative approach has the potential to improve patient outcomes through early detection and intervention.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…